Regenerative Medicine · Updated September 2026
Exosome Therapy
Exosome therapy represents the next frontier in regenerative medicine. Exosomes are nano-sized extracellular vesicles released by stem cells that carry powerful signaling molecules — growth factors, cytokines, and genetic material — that direct tissue repair and modulate the immune response. At IPC, exosome therapy is used as a standalone treatment or combined with stem cell and PRP protocols to amplify regenerative outcomes.
Conditions Treated
Joint osteoarthritis, chronic tendon injuries, degenerative disc disease, neuropathic pain, chronic inflammatory conditions, patients seeking enhanced regenerative outcomes
How It Works
Exosomes derived from mesenchymal stem cells are delivered directly to the treatment site via precise image-guided injection. These nano-vesicles penetrate target tissues and deliver regenerative signals that recruit the body's own repair cells, reduce inflammation, and promote new tissue formation — without the need for live cell transplantation.
What to Expect
30-60 minute procedure. Similar to receiving a standard injection. Minimal discomfort during and after the procedure. No harvest site needed since exosomes are prepared from lab-processed donor mesenchymal cells.
Recovery
Minimal downtime. Most patients return to normal activities within 24-48 hours. Avoid anti-inflammatory medications for 2 weeks. Full effects develop over 4-8 weeks.
Duration of Relief
How long the effect holds depends on which tissue was treated and on the diagnosis behind the pain.
Powered By
Limitless Performance Medicine
Our regenerative medicine program is powered by Limitless Performance Medicine — advanced regenerative protocols delivered with interventional pain precision. Limitless is a separate practice founded and owned by Dr. Joshua Hare, IPC's Founder & Medical Director.
Learn More at Limitless →Request a callback
The team calls you back within one business day, Monday to Thursday.
Book a visit
Our fellowship-trained physicians are accepting new patients at 7 locations across North Georgia and East Tennessee.